SEC FORM 4
$88,080.00
Mirum Pharmaceuticals, Inc. (MIRM)
Acquisition (code M) of 30,000 shares at $2.936 per share.
Reporting Person Peetz Christopher · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code M
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001614740-26-000013 · filed 2026-09-03 · View filing →